Cancer Archives - Market Exclusive

Home Tags Cancer

Pharmacyte Nears Approval Of Lead Product Utilizing Live-Cell Encapsulation

ME Staff - February 5, 2019

Loxo Oncology Inc (NASDAQ:LOXO): What Just Happened?

ME Contributor - June 6, 2017

DelMar Pharmaceuticals Inc. (NASDAQ:DMPI) Moves Forward With Flagship Chemotherapy Into Phase...

David Rich - February 6, 2017

Here’s What To Look For When The Real GTx, Inc. (NASDAQ:GTXI)...

ME Contributor - November 17, 2016

What’s The Deal Between MetaStat Inc. (OTCMKTS:MTST) And Celgene Corporation (NASDAQ:CELG)?

David Rich - October 10, 2016

What To Look For In The Upcoming Oncomed Pharmaceuticals Inc (NASDAQ:OMED)...

ME Contributor - August 17, 2016

What’s Next For CytRx Corporation (NASDAQ:CYTR) Holders?

ME Contributor - July 13, 2016

Merck & Co., Inc. (NYSE:MRK), Pfizer Inc. (NYSE:PFE), Eye Cannabis Acquisitions

ME Contributor - June 14, 2016

Here’s All You Need To Know About Seattle Genetics, Inc.’s (NASDAQ:SGEN)...

ME Contributor - May 26, 2016

Halozyme Just First-Dosed in a Blockbuster Oncology Phase III

ME Staff - March 17, 2016

12 Page 1 of 2

/* */

EDITOR PICKS

Cannabis Stock News Daily Roundup April 12

April 12, 2019

Market Morning: Alexa Spying, Boeing Sensor History, Macron Spoils Scallop Dinner

April 11, 2019

ICC, AgraFlora to Bring Native Colombian Cannabis Strains to 39K Retail...

April 10, 2019

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: Cancer